Gemini Therapeutics Inc To Discuss Merger with Disc Medicine Inc Call Transcript
Welcome to today's joint call with Gemini Therapeutics and Disc Medicine. Our speakers today are George Gemayel, Chair of the Board and Interim CEO of Gemini Therapeutics, and John Quisel, President and CEO of Disc Medicine.
Gemini's strategic review was a thorough and thoughtful process. We believe that this transaction presents an exciting opportunity for our shareholders as this has built a diversified clinical-stage pipeline of product candidates. And we believe in the ability of Disc's experienced management team to lead the combined company. We look forward to its continued success. John will now provide an overview of Disc Medicine and the company's hematology drug development programs.
Thank you, George, and good morning, everyone. Before I begin, I want to remind everyone that this discussion and the accompanying presentation will contain forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |